Eli Lilly & Co.

( )
LLY After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.21%149.480.7%$741.20m
BMYBristol-Myers Squibb Co. 1.06%67.431.0%$732.45m
PFEPfizer Inc. -0.40%40.350.9%$572.52m
MRKMerck & Co., Inc. -1.11%89.960.7%$567.99m
ABBVAbbVie, Inc. 0.00%88.002.3%$549.02m
LLYEli Lilly & Co. 0.96%140.921.1%$394.62m
APLSApellis Pharmaceuticals, Inc. 6.27%43.040.0%$117.42m
NVSNovartis AG -0.78%95.190.2%$109.87m
AZNAstraZeneca Plc -1.04%50.801.2%$95.45m
GSKGlaxoSmithKline Plc -0.81%47.500.2%$89.73m
KRTXKaruna Therapeutics, Inc. 4.57%109.300.0%$65.08m
NVONovo Nordisk A/S -0.26%61.150.1%$64.59m
RETAReata Pharmaceuticals, Inc. 0.71%212.933.5%$64.21m
SNYSanofi -2.01%50.210.2%$58.92m
RARXRa Pharmaceuticals, Inc. -0.23%46.860.8%$36.84m

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.